“The
Report Global Combined Hormonal Contraceptives (CHC) Market: Trends
and Opportunities (2014-19) provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz”
Scope
of the Report
The report titled “Global
Combined Hormonal Contraceptive (CHC) Market: Trends and
Opportunities (2014-2019)” provides an in-depth analysis of the
global CHC market with detailed analysis of market sizing and growth,
market share and economic impact of the industry. The report also
assesses key opportunities in the market and outlines the factors
that are and will be driving growth of the industry. Growth of the
overall CHC industry has also been forecasted for the period 2014-19,
taking into consideration the previous growth patterns, the growth
drivers and the current and future trends. An insight into strategic
issues affecting key brands on the market is provided followed by an
analysis of the leading companies in the hormonal contraceptives
market. The report also analyzes the key CHC products in
pipeline.Further, key players of the industry like Agile
Therapeutics; Bayer Healthcare; Teva Pharmaceuticals and Actavis PLC;
are analyzed in the report.
View Full Report at
http://www.marketresearchreports.biz/analysis/242913
- Country Coverage
- United states
- United Kingdom
- India
- China
- Japan
- Company Coverage
- Agile Therapeutics Inc.
- Actavis Plc.
- Bayer Healthcare
- Teva Pharmaceuticals
Executive
Summary
Combined Hormonal
Contraceptives (CHC) is widely being used as an effective and
reversible birth control method. Mainly used for preventing
pregnancies but sometimes also used for treating acne vulgaris,
endometriosis, polycystic ovarian syndrome and irregular menstrual
flow, CHC works by preventing ovulation i.e. release of egg from
ovaries. The hormones are provided in the combined pill, patch or
ring.
Download Detail Report With
Complete TOC at
http://www.marketresearchreports.biz/sample/sample/242913
Most popular Combined Hormonal
Contraceptives products are Nuvaring and Ortho Evra. CHC products are
broadly used throughout the world by women in the age-group of 15 to
49 years. With increasing health consciousness and awareness,
adoption of CHC products or birth control methods is increasing in
lesser privileged economic segments too. The growth of CHC market is
driven by urbanization and increasing user awareness, rise in
menstruating population globally and initiatives taken by governments
to encourage the use of contraception. Major trends prevailing in the
market are the increasing number of mergers and acquisitions in this
business space and demand for reversible method of contraception with
fewer side effects.
Table
Of Content
1. EXECUTIVE SUMMARY
2. COMBINED HORMONAL
CONTRACEPTIVES MARKET: AN OVERVIEW
2.1 Definition
2.2 History
2.3 Classification
2.3.1 Combined Oral
Contraceptive Pills
2.3.2 Combined Vaginal Rings
2.3.3 Combined Transdermal
Patches
2.3.4 Combined Injectable
Birth Control
2.3.5 Combined Emergency
Contraceptive Pills
2.4 Mechanism of Action
2.5 Components of CHCs
2.6 Advantages of Combined
Hormonal Contraceptives
2.7 Disadvantages of Combined
Hormonal Contraceptives
2.8 Contraindications
2.9 Serious Risks
3. COMBINED HORMONAL
CONTRACEPTIVES(CHC) MARKET ANALYSIS
3.1 Global CHC Market Sizing
and Growth
3.2 Global CHC Market Breakup:
Branded vs. Generic
3.3 CHC Generic Market
3.4 Global CHC Branded Market
4. COMBINED HORMONAL
CONTRACEPTIVES(CHC): MARKET SHARE ANALYSIS
4.1 Global CHC Market Share by
Class
4.2 Global CHC Market Share by
Key Players
4.3 Global CHC Market Share by
Key Products
Related
Reports
Large
Degree of Innovation in Parkinson’s Disease Pipeline
The Parkinson’s disease (PD)
pipeline currently has 302 products in active development across all
stages, but a stark contrast between the mechanisms of action
employed in the current market and the pipeline is evident. Where the
market relies on symptomatic treatments that target neuromodulatory
receptors, the pipeline shows a diverse range of neuroprotective
therapies targeting dysfunctional disease processes. This diversity
is partially due to the presence of 90 first-in-class products, which
accounts for 37% of the overall pipeline therapies that disclosed
their target. In an industry, market and development landscape that
favors first-in-class over non-first-in-class development in many
ways, such as through faster approval or greater revenue, this
finding has strategic implications for a wide array of market
participants, both large and small. Despite their historically high
attrition rate, first-in-class therapies that reach the market have
the potential to transform and improve the PD treatment landscape.
Dentistry is the branch of
medical science which encompasses diagnosis, treatment &
prevention of diseases of the teeth, gums and supporting bones. One
of the major segments of dental industry is implant dentistry. The
market for implant dentistry comprises dental implants and abutments
as well as supporting tools/instruments. The global market for dental
care is bifurcated into two segments: dental consumables and dental
equipments. Dental consumables is a major segment of the dental care
industry, which includes crowns/bridges, implants, orthodontics,
impressive materials, composites, endodontics, adhesives, and
cements, while the dental equipment segment is composed of large
equipment, like autoclaves, sterilizers, chairs, communication
systems, compressors, cuspidors, and digital imaging systems.
About
Us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Contact
Us
Office:
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
E:
sales@marketresearchreports.biz
No comments:
Post a Comment